Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08K Sell
1,037
-16,807
-94% -$16.4K ﹤0.01% 5407
2026
Q1
$12.1K Buy
17,844
+11,144
+166% +$9.13K ﹤0.01% 4968
2025
Q4
$6.1K Buy
6,700
+4,248
+173% +$4.07K ﹤0.01% 5193
2025
Q3
$2.19K Sell
2,452
-9,107
-79% -$13.3K ﹤0.01% 5462
2025
Q2
$25K Buy
+11,559
New +$41.9K ﹤0.01% 5025
2025
Q1
Sell
-202
Closed -$1.3K 5819
2024
Q4
$1.3K Buy
+202
New +$983 ﹤0.01% 5577

Other funds holding MYO

Citigroup's MYO Position: Q2 2026 in Review

Citigroup reduced its Myomo (MYO) stake by 94% in Q2 2026, selling an estimated $16.4K and leaving 1,037 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5407.

Citigroup first reported a position in MYO in Q4 2024 and has held it in 6 quarters since. The position peaked at $25K in Q2 2025. 80 funds tracked by Wall St. Rank hold MYO as of Q2 2026.

  • Citigroup held 1,037 shares of Myomo worth $1.08K as of Q2 2026.
  • Citigroup sold 16,807 Myomo shares in Q2 2026, an estimated $16.4K.
  • Myomo made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5407 holding.
  • Citigroup first reported a position in Myomo in Q4 2024 and has held it in 6 quarters since.
  • Citigroup's Myomo position peaked at $25K in Q2 2025.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.